| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |